Dr. Jeff Joy

Research Scientist

Dr. Jeffrey Joy is a research scientist (evolutionary genetics and bioinformatics) at the BC Centre for Excellence in HIV/AIDS (BCCfE) in the laboratory program and an Assistant Professor of medicine at the University of British Columbia.

 

Dr. Joy’s work is currently focused on the dynamics of the Canadian HIV and HCV epidemics, development of clinical assays for HIV and HCV drug resistance, within-host viral evolution, rates of turnover in HIV cellular reservoirs as well as rates of migration between them, and development of novel methods for understanding epidemic dynamics based on sequence data.

 

His research interests include evolutionary epidemiology, virus evolution, phylogenetics, population genetics, molecular evolution, and bioinformatics. Dr. Joy has publications in the world’s top journals (including two in the journal Nature and most recently one in the Lancet Infections Diseases), he has a strong interest in translating evolutionary genetics to problems related to human health and disease.

Scroll to Top

During the Canada Post strike announced September 25, 2025, the following measures will be undertaken to minimize service disruption to BC-CfE clients and providers.

  • The BC-CfE Laboratory has transitioned to private courier for delivery of outgoing reports and documents. Results required urgently can be faxed upon request. (Lab Contact Information: Phone 604-806-8775; FAX 604-806-9463)
  • The BC-CfE Drug Treatment Program (DTP) will fax outgoing forms and documents to the provider’s office. (DTP Contact Information: Phone 604-806-8515; FAX 604-806-9044)
  • St. Paul’s Hospital Ambulatory Pharmacy has transitioned to private courier for delivery of medications. We recommend requesting medication at least 2 weeks in advance in case of delivery delays, particularly to rural/remote parts of BC. (Contact Information: Phone 1-800-547-3622; FAX 604-806-8675)

During the Canada Post strike, we recommend that documents be faxed or couriered to our sites, versus utilization of regular mail service

The BC-CfE Laboratory is streamlining reporting processes for certain tests in order to simplify distribution and record-keeping, and to ensure completeness of results. Beginning September 2, 2025, results for the ‘Resistance Analysis of HIV-1 Protease and Reverse Transcriptase’ (Protease-RT) and ‘HIV-1 Integrase Resistance Genotype’ tests will be combined into a single ‘HIV-1 Resistance Genotype Report’.
For more details and example reports, please click on the button below